Conditions: Healthy
Keywords: Healthy subjects Opioid Healthy volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 92
Healthy volunteers: yes

Brief summary:
The purpose of this study is to assess the bioequivalence of a new oxycodone formulation (40 mg) relative to the original OxyContin® (OXY) formulation (40 mg) in the fasted state.

Detailed description:
Oxycodone hydrochloride (oxycodone) is a semi-synthetic opioid analgesic that is effective in the relief of moderate to severe malignant and non-malignant pain.

Arms:
arm 1: Reformulated OXY 40 mg x 1 dose arm 2: Original OxyContin® (OXY) 40 mg x 1 dose

Interventions: intervention 1: Reformulated OXY (oxycodone HCl) intervention 2: Original OxyContin® (OXY) (oxycodone HCl)
Intervention descriptions: intervention 1: Reformulated OXY 40-mg tablet x 1 dose taken without food intervention 2: Original OxyContin® (OXY) 40-mg tablet x 1 dose taken without food

Protocol document: